U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07266818) titled 'A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)' on Dec. 01.

Brief Summary: The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.

Study Start Date: Dec. 17

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: MK-1167

Oral capsule administered once daily

DRUG: Placebo

Oral capsule administered once daily

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Merck Sharp & Dohme LLC

Published by HT Digital Content Services with permission from Health Daily Digest....